Cover Image MEDALLIANCE
MEDALLIANCE

MEDALLIANCE

Summary


MedAlliance is a developer of medical technology headquartered in Nyon, Switzerland. The company develops sirolimus micro-reservoir drug-coated balloon to treat patients suffering from peripheral artery disease (PAD), coronary artery disease (CAD), arteriovenous fistulas (AVF) and grafts (AVG) for end-stage renal disease.

Deals Overview

Total Deals2
Valued Deals2
Total Value£1,038M
Avg. Deal Size£519M

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US